Search Results 41-50 of 16173 for monoclonal antibody

1. Fusion and Screening - Antibody Hybridoma Core - Mayo Clinic Research

   The Western blot is a technique used to identify candidate hybrids, clones, subclones and monoclonal antibodies of interest that recognize and bind to one ...

2. Immunization and Antiserum Collection - Antibody Hybridoma Core - Mayo Clinic Research

   The Antibody Hybridoma Core at Mayo Clinic produces monoclonal antibodies using immunized mice housed in a pathogen-free colony.

3. Hodgkin's Lymphoma Clinical Trials

   Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...

4. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

   A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies · Overview · Participation eligibility.

5. Antibody Hybridoma Core - Mayo Clinic Research

   Purified monoclonal antibodies can be labeled with fluorescein isothiocyanate, biotin and rhodamine fluorochromes. Antibody samples to be labeled should each be ...

6. Glioblastoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as anti-endoglin monoclonal antibody TRC105 and bevacizumab, may find tumor cells and help kill them. Giving anti-endoglin ...

7. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Monoclonal antibodies can block cancer growth in different ways. ... Prior anti-cancer monoclonal antibody < 28 days prior to registration or who ...

8. A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas - Mayo Clinic

   A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory ...

9. Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13 - Mayo Clinic

   Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13 · Overview · Participation eligibility.

10. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

    Monoclonal antibodies, such as varlilumab and nivolumab, may work by ... History of severe hypersensitivity reaction to any monoclonal antibody.